Revenue Growth Benchmarks
Top-line performance metrics of companies across industries and countries
Top 10 Immunology Pharma and Biotech Companies
In the last fiscal year, only three companies Johnson & Johnson, Sanofi and Amgen reported growth in revenues while Pfizer was the laggard reporting 42% decline in annual revenues. However, these companies grew at an average of 5% over the last 5 years.
[ 1: LTM Sales in USD Biliion | Red Shading: Companies with negative growth in period | Green Shading: Top 2 companies by growth rank in period ]
Company | HQ | Reported | Latest | LTM | year-on-year % | CAGR | Growth Rank | ||||||||||||
Currency | FQ | Sales1 | 3m | 6m | 9m | ltm | 1y | 2y | 3y | 5y | 6m | LTM | 3ycagr | 5ycagr | |||||
Johnson & Johnson | USA | USD | 2023-12 | 93.02 | 7.3% | 7.0% | 6.8% | 6.5% | 6.5% | 4.0% | 1.0% | 0.9% | 2 | 2 | 8 | 8 | |||
Roche Holding AG | CHE | CHF | 2023-12 | 67.29 | na | -6.5% | na | -8.2% | -8.2% | -1.9% | 1.2% | 1.2% | 9 | 9 | 7 | 7 | |||
Pfizer Inc | USA | USD | 2023-12 | 58.50 | -41.3% | -41.4% | -46.1% | -41.7% | -41.7% | -15.2% | 12.0% | 7.5% | 10 | 10 | 2 | 4 | |||
AbbVie Inc | USA | USD | 2023-12 | 54.32 | -5.4% | -5.7% | -5.4% | -6.4% | -6.4% | -1.7% | 5.8% | 10.6% | 8 | 8 | 4 | 3 | |||
Novartis AG | CHE | CHF | 2023-12 | 51.02 | -0.3% | 1.7% | 0.6% | 1.1% | -0.3% | -0.2% | -3.1% | -2.5% | 3 | 5 | 9 | 9 | |||
Sanofi SA | FRA | EUR | 2023-12 | 50.27 | na | 1.2% | na | 2.3% | 2.3% | 8.9% | 7.5% | 5.4% | 4 | 3 | 3 | 5 | |||
AstraZeneca PLC | GBR | GBP | 2023-12 | 45.80 | 3.2% | -0.6% | 0.7% | 1.4% | -0.6% | 13.4% | 22.3% | 15.7% | 5 | 4 | 1 | 1 | |||
Bristol-Myers Squibb Co | USA | USD | 2023-12 | 45.01 | 0.6% | -0.8% | -2.4% | -2.5% | -2.5% | -1.5% | 1.9% | 14.8% | 6 | 6 | 6 | 2 | |||
Amgen Inc | USA | USD | 2023-12 | 28.19 | 19.8% | 11.9% | 10.0% | 7.1% | 7.1% | 4.2% | 3.5% | 3.5% | 1 | 1 | 5 | 6 | |||
Biogen Inc | USA | USD | 2023-12 | 9.84 | -6.2% | -2.7% | -3.5% | -3.3% | -3.3% | -5.4% | -9.9% | -6.1% | 7 | 7 | 10 | 10 | |||
Source: Annual Filings, Company Website | |||||||||||||||||||
Decide Fearlessly
Aranca is a global research analytics and advisory firm with over 20 years of experience in helping organizations take strategic business and investment decisions fearlessly and with utmost conviction.
Reach out to us
© , Aranca. All rights reserved.